Abstract CT567: Comprehensive measures of COVID-19 vaccine efficacy in adolescent cancer patients: Results from SerOzNET
Eva Segelov(University of Bern), Elizabeth Ahern(Monash Health), Corey Smith(QIMR Berghofer Medical Research Institute), Noemi Fuentes Bolanos(Children's Cancer Institute Australia), Katie E. Lineburg(QIMR Berghofer Medical Research Institute), Sudha Rao(QIMR Berghofer Medical Research Institute), Vi Luong(Monash Health), Tracey O’Brien(Sydney Children's Hospital), Stuart Turville(UNSW Sydney), Bhavna Padhye(Children's Hospital at Westmead), Veronica Aedo Lopez(Monash Health), Hesham Abdulla(Suez Canal University), Antoinette Anazodo(Sydney Children's Hospital), Robert McCuaig(University of Canberra), C. Raina MacIntyre(UNSW Sydney), Luxi Lal(Monash Health), Stephen Opat(Monash Health), Amy Body(Monash Health), Peter Downie(Monash Children’s Hospital), Zin Niang(UNSW Sydney)
Cited by 0
Related Papers
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
|Blood|2019|369
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
|Journal of Clinical Pathology|1984|261